HPV infection among women in a representative rural and suburban population of the USA

International Journal of Gynecology and Obstetrics

Volumn 105, Issue 3, 2009, Pages 210-214

  Lee, Sin Hang ^a   Vigliotti, Veronica S ^a   Pappu, Suri ^a  

^a Milford Hospital   (United States)

Author keywords

DNA sequencing; HPV genotyping; Suburban USA

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CANCER RISK; CLINICAL EVALUATION; COLPOSCOPY; CYTOLOGY; DNA SEQUENCE; FEMALE; GENOTYPE; GYNECOLOGY; HIGH RISK POPULATION; HISPANIC; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 52; INFECTION RISK; POLYMERASE CHAIN REACTION; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; PRIVATE PRACTICE; RURAL AREA; SUBURBAN AREA; UNITED STATES; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 66949177097     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2009.01.019     Document Type: Article

References (25)

1. Lu H., Ouyang W., and Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 4 4 (2006) 221-233
2. Wallin K.L., Wiklund F., Angström T., Bergman F., Stendahl U., Wadell G., et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341 22 (1999) 1633-1638
3. Kjaer S.K., van den Brule A.J., Paull G., Svare E.I., Sherman M.E., Thomsen B.L., et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 325 7364 (2002) 572-576
4. Sherman M.E., Lorincz A.T., Scott D.R., Wacholder S., Castle P.E., Glass A.G., et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 95 1 (2003) 46-52
5. Ortiz M., Torres M., Munoz L., Fernandez-Garcia E., Canals J., Cabornero A.I., et al. Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk. J Clin Microbiol 44 4 (2006) 1428-1434
6. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al. Prevalence of HPV infection among females in the United States. JAMA 297 8 (2007) 813-819
7. Brown D.R., Shew M.L., Qadadri B., Neptune N., Vargas M., Tu W., et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 191 2 (2005) 182-192
8. Lindau S.T., Drum M.L., Gaumer E., Surawska H., and Jordan J.A. Prevalence of high-risk human papillomavirus among older women. Obstet Gynecol 112 5 (2008) 979-989
9. American College of Obstetrics and Gynecologists. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetricians-Gynecologists. Number 61, April 2005. Human papillomavirus. Obstet Gynecol 105 4 (2005) 905-918
10. Milford city (balance), Connecticut State and County QuickFacts. U.S. Census Bureau. Available at: www.census.gov.
11. Hovey D, State must do more to prevent cervical cancer. Available at: http://www.housegop.ct.gov/%5Cpressrel%5CHoveyD112%5C2007%5C20070116_HoveyD112_01.pdf.
12. Lee S.H., Vigliotti V.S., Vigliotti J.S., and Pappu S. Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories. Infect Agent Cancer 2 (2007) 11
13. Lee S.H., Vigliotti V.S., and Pappu S. DNA sequencing validation of Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid tests. Am J Clin Pathol 129 6 (2008) 852-859
14. Gharizadeh B., Oggionni M., Zheng B., Akom E., Pourmand N., Ahmadian A., et al. Type-specific multiple sequencing primers: a novel strategy for reliable and rapid genotyping of human papillomaviruses by pyrosequencing technology. J Mol Diagn 7 2 (2005) 198-205
15. Paulo M., Borges A.B., Duarte G., Quintana S.M., Montes M.B., and Toloi M.R. The environmental cofactors in carcinogenesis in high risk HPV/HIV-positive women. Braz J Infect Dis 11 2 (2007) 189-195
16. Rodríguez A.C., Schiffman M., Herrero R., Wacholder S., Hildesheim A., Castle P.E., et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 100 7 (2008) 513-517
17. Schmitt M., Bravo I.G., Snijders P.J., Gissmann L., Pawlita M., and Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 44 2 (2006) 504-512
18. Klug S.J., Molijn A., Schopp B., Holz B., Iftner A., Quint W., et al. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J Med Virol 80 7 (2008) 1264-1274
19. van Doorn L.J., Quint W., Kleter B., Molijn A., Colau B., Martin M.T., et al. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J Clin Microbiol 40 3 (2002) 979-983
20. Johnson T., Bryder K., Corbet S., and Fomsgaard A. Routine genotyping of human papillomavirus samples in Denmark. APMIS 111 3 (2003) 398-404
21. Speich N., Schmitt C., Bollmann R., and Bollmann M. Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. J Med Microbiol 53 Pt 2 (2004) 125-128
22. Asato T., Maehama T., Nagai Y., Kanazawa K., Uezato H., and Kariya K. A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. J Infect Dis 189 10 (2004) 1829-1832
23. Stout N.K., Goldhaber-Fiebert J.D., Ortendahl J.D., and Goldie S.J. Trade-offs in cervical cancer prevention: balancing benefits and risks. Arch Intern Med 168 17 (2008) 1881-1889
24. Centers for Disease Control and Prevention. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections, 2002. MMWR Morb Mortal Wkly Rep 51 RR15 (2002) 1-27
25. Altman D.G., and Bland J.M. Diagnostic tests 2: predictive values. BMJ 309 6947 (1994) 102